Patient Rights at the Center of a New Report by Dr. Nalini M. Rajamannan
CHICAGO, May 6, 2019 /PRNewswire/ -- The final clues are falling into place in a 12-year-old mystery about how patient protections were bypassed during open heart surgery for hundreds of patients and published in the American Association of Thoracic Surgeons Journal. The Society celebrated their 99th anniversary in Toronto, CA this past weekend.
The Model 5100 heart valve ring was implanted into nearly 700 patients without their consent or approval from the Food and Drug Administration.
Documents recently obtained through a Freedom of Information Act request outline how this practice escaped regulatory notice.
On Thursday, one of the Model 5100 patients was in a Chicago courtroom, seeking a new trial in a malpractice lawsuit due to the newly released documents. Her petition alleges fraudulent concealment of critical information, which is now public. The defendants asked for the petition to be dismissed and have a month to file documents explaining why they are not moving forward on the newly discovered FDA FOIA which falls under Northwestern UniversityFWA federal laws. The patient's attorneys will have 21 days to respond.
"He was putting it into patients, seeing how it worked, and not telling them," Obermeier's attorney Adrwin Boyer said during opening statements of the 2016 court trial in Cook County, according to Fox 32 in Chicago.
Meanwhile, a cardiologist who removed herself from the Model 5100 device study when she realized patients hadn't given their consent, published a report on Saturday (May 4) to highlight key facts and documents in the case:
Patients began receiving the controversial heart valve ring in 2006.
Testing of the device was officially closed by Northwestern University officials as of June 2006, but the final publication of the clinical study published in the American Association of Thoracic Surgery's premier journal in July 2008 reveals that the study continued without patient consent and without the university approval until November 2007.
The device was invented by the surgeon implanting it and wasn't approved by the FDA.
United States Sen. Charles Grassley (IA) requested evidence as part of the Senate Investigation.
Over the six-year investigation, the documents, responses and letters were reviewed by Dr. Nalini Rajamannan, the cardiologist who removed herself from the Model 5100 study.
Initially, the surgeon, device maker and hospital claimed the documents received by the Senate committee were for senators' eyes only, but during a court hearing attorneys confirmed that any privilege under the Standing Rules of the Senate did not pertain to the documents. Senate Rule XXIX provides privilege only to the Executive Branch under the Constitution of the United States of America for executive sessions as related to matters of national security.
Rajamannan's report, The Myxo File X and the Myxo Report, offers a comprehensive look at the Senate Finance and Senate Judiciary Investigations from 2008-2014 for the 667 heart valve patients, media, regulators, lawmakers and patients' rights advocates.
The Myxo File X published Saturday, May 4, 2019 on Amazon.com also provides an in-depth analysis by Dr. Rajamannan, an eye-witness to the human experiments, regarding the release of responses sent to the Senate.
Dr. Nalini Rajamannan is a heart valve expert in the field of cardiovascular medicine. She has been researching heart valve disease for 31 years. She earned her undergraduate science pre-professional degree from the University of Notre Dame, her Medical Doctorate from Mayo Medical School and her post-graduate training in Internal Medicine and Cardiology at the Mayo Clinic. She also worked at the Mayo Clinic as a staff consultant in Internal Medicine. Currently, she practices consultative medicine specializing in Cardiac Valvular Heart Disease at Most Sacred Heart of Jesus Cardiology and Valvular Institute, WI.
Yoneda Labs, the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator....
People USA, funded by and in partnership with the New York State Office of Mental Health (OMH), is set to open 20 new scattered site housing units that will support individuals re-entering the community from New...
Harbor Point at Centerville, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the third straight year. In U.S. News & World Report's third annual...
Crescent Point at Niantic, a Benchmark assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Connecticut and the entire U.S. for the third straight year. In U.S. News & World...
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...